TY - JOUR T1 - Use of prognostic markets to guide biologic therapies for rheumatoid arthritis. JF - The Journal of Rheumatology JO - J Rheumatol SP - 2662 LP - 2662 VL - 29 IS - 12 AU - Christopher A D'Arcy AU - Robert F Willkens Y1 - 2002/12/01 UR - http://www.jrheum.org/content/29/12/2662.abstract N2 - 300 Multiple ChoicesThis is a pdf-only article and there is no markup to show you.full-text.pdf ER -